Investigator: Dale Hamilton, MD

Study Coordinator: Melissa Whipple

Status: Open Not Enrolling

ClinicalTrials.gov Number: NCT02312687

Phone: 713.441.3247

Protocol Number: Pro00011983


The primary purpose of this study is to assess the safety and efficacy of repeated subcutaneous (SC) injections of KRN23 in adult subjects with X-Linked Hypophosphatemia (XLH). A Bone Substudy will evaluate the effects of single-blind KRN23 versus Placebo on bone mineral density, bone quality and histomorphometric parameters.
More to Explore
Live Chat Available